Edition:
United States

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

9.92USD
1:02pm EDT
Change (% chg)

$0.96 (+10.71%)
Prev Close
$8.96
Open
$9.00
Day's High
$10.21
Day's Low
$8.95
Volume
116,580
Avg. Vol
80,377
52-wk High
$22.51
52-wk Low
$7.60

Chart for

About

Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The Company’s initial focus is on the treatment of eye diseases. The Company’s product candidate includes KPI-121 1%, KPI-121... (more)

Overall

Beta: --
Market Cap(Mil.): $266.49
Shares Outstanding(Mil.): 32.11
Dividend: --
Yield (%): --

Financials

  KALA.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -3.23 -- --
ROI: -88.62 1.96 12.83
ROE: -- 1.12 14.95

FDA approves Kala Pharma's eye pain drug

The U.S. Food and Drug Administration on Thursday approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.

Aug 23 2018

U.S. FDA approves Kala Pharma's eye pain drug

Aug 23 The U.S. Food and Drug Administration on Thursday approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.

Aug 23 2018

BRIEF-Kala Pharmaceuticals Reports Q1 Loss Per Share Of $0.46

* KALA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 10 2018

BRIEF-Kala Pharmaceuticals - PDUFA Target Action Date For Inveltys Is August 24, 2018

* KALA PHARMACEUTICALS INC - PDUFA TARGET ACTION DATE FOR INVELTYS IS AUGUST 24, 2018 Source text for Eikon: Further company coverage:

May 09 2018

Earnings vs. Estimates